Ganem, Fernando <br/><br/>
Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery.  [electronic resource] 

 -  Interactive cardiovascular and thoracic surgery  May 2011 
 - 778-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-9285 
<br/><br/><label>Standard No.: </label>10.1510/icvts.2010.255257  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrylamides--blood<br/>Aged<br/>Biomarkers--blood<br/>Brazil<br/>C-Reactive Protein--metabolism<br/>Cardiac Surgical Procedures--adverse effects<br/>Cardiopulmonary Bypass--adverse effects<br/>Cardiotonic Agents--therapeutic use<br/>Chi-Square Distribution<br/>Dobutamine--therapeutic use<br/>Female<br/>Hospital Mortality<br/>Humans<br/>Inflammation--blood<br/>Inflammation Mediators--blood<br/>Intensive Care Units<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Intra-Aortic Balloon Pumping<br/>Length of Stay<br/>Male<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>P-Selectin--blood<br/>Postoperative Complications--blood<br/>ROC Curve<br/>Respiration, Artificial<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>beta-Alanine--analogs & derivatives